Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: ADV-TK Improves Outcome of Recurrent High-Grade Glioma [Phase 2]
Phase 2 trial of ADV-TK in recurrent high-grade glioma reports improved outcomes in malignant glioma and glioblastoma. The study is complete…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Sunitinib to Treat Recurrent Brain Cancer [Phase 2]
A Phase 2 trial of sunitinib for recurrent brain cancer (glioblastoma, malignant glioma, and anaplastic glioma) was terminated with results …
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM [Phase 2]
Phase 2 trial evaluating sorafenib plus protracted temozolomide in recurrent glioblastoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating vorinostat (SAHA) with bevacizumab and daily temozolomide for recurrent malignant gliomas, including g…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma [NA]
A completed clinical trial update describing a pharmacologic study of methotrexate in patients with recurrent high-grade glioma undergoing s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating temozolomide in adults with newly diagnosed primary malignant glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas [Phase 1]
A Phase I study of temozolomide combined with O6-benzylguanine and irinotecan in patients with recurrent or progressive cerebral anaplastic …
-
CLINICAL_TRIALS withdrawal · 2013-06-19Clinical Trial Update: A Panobinostat Presurgery [Phase 2]
A presurgical Phase 2 trial of panobinostat for recurrent glioblastoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating motexafin gadolinium with radiation therapy for newly diagnosed glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
This clinical trial evaluated FLT PET and MRI imaging biomarkers to assess early treatment response in glioblastoma; the study status is com…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma [Phase 2]
A Phase 2 clinical trial evaluating ritonavir and lopinavir for progressive or recurrent high-grade glioma was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme [Phase 1]
This document reports the completion of a Phase 1 trial evaluating radiation therapy with gadolinium texaphyrin for supratentorial glioblast…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Curcumin Bioavailability in Glioblastoma Patients
A completed clinical trial evaluated the bioavailability of curcumin in patients with glioblastoma undergoing surgery.
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma [Phase 3]
Phase 3 trial of bevacizumab with temozolomide and radiotherapy in newly diagnosed glioblastoma completed; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Borderzone Sampling [NA]
Clinical trial update noting completion of a Maastricht University Medical Center study on borderzone sampling in high-grade glioma and glio…
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) [Phase 2]
This document reports the completed Phase II trial results for bevacizumab plus erlotinib in patients with recurrent malignant glioma, inclu…
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas
This completed clinical trial investigates a protocol to distinguish tumor recurrence from treatment-related necrosis in patients with recur…
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma [Phase 2]
Phase 2 study of Gamma Knife radiosurgery using MRI spectroscopy for recurrent glioblastoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma [Phase 2]
Phase 2 trial update reporting results for bevacizumab in combination with metronomic temozolomide in recurrent malignant glioma, including …
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]
Phase 1 study evaluating the combination of temsirolimus, temozolomide, and radiation therapy in newly diagnosed glioblastoma; the trial sta…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating tipifarnib with radiation therapy for newly diagnosed glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma [Phase 1]
Phase 1 trial evaluating arsenic trioxide with radiation therapy in newly diagnosed malignant glioma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme [Phase 2]
Phase II trial of erlotinib plus sirolimus in recurrent malignant glioma (glioblastoma and gliosarcoma) has completed and results were poste…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572) [Phase 4]
A Phase 4 trial comparing standard Temozolomide alone to standard Temozolomide with early postoperative Temozolomide in newly diagnosed glio…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG) [Phase 2]
Phase II study of imatinib plus hydroxyurea in patients with recurrent or progressive grade II low-grade glioma; trial completed with result…